Inventor · disambiguated record
Joseph E. Blaney
Also filed as: BLANEY JOSEPH · BLANEY JOSEPH E · BLANEY JR JOSEPH E
31 granted patents·2 pending applications·129 citations·filing 2003–2024
97Inventor score
Files withUS HEALTH13THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES5WHITEHEAD STEPHEN S4BLANEY JOSEPH E2THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES2
Top patents by PatentIndex Score
33 records- 0194USRE46042EDevelopment of dengue virus vaccine componentsUS GOVERNMENT·Filed 2007·Granted Jun 28, 2016·8 cites·14 claims
- 0292US2025236848A1Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2024·Application pending·0 cites
- 0391US9090873B2Development of dengue virus vaccine componentsUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2012·Granted Jul 28, 2015·5 cites·19 claims
- 0491US8632782B2Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated regionWHITEHEAD STEPHEN S·Filed 2011·Granted Jan 21, 2014·10 cites·17 claims
- 0591US8075903B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4WHITEHEAD STEPHEN S·Filed 2009·Granted Dec 13, 2011·14 cites·36 claims
- 0690US8337860B2Development of dengue virus vaccine componentsWHITEHEAD STEPHEN S·Filed 2007·Granted Dec 25, 2012·6 cites·14 claims
- 0790US8039003B2Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesisUS HEALTH·Filed 2009·Granted Oct 18, 2011·8 cites·10 claims
- 0890US7560118B2Attenuated dengue virus comprising mutations in the NS3 geneUS HEALTH·Filed 2006·Granted Jul 14, 2009·8 cites·16 claims
- 0989US12203100B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2023·Granted Jan 21, 2025·0 cites·3 claims
- 1088USRE46631EDengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Dec 12, 2017·7 cites·42 claims
- 1188US7226602B2Development of mutations useful for attenuating dengue viruses and chimeric dengue virusesUS HEALTH·Filed 2003·Granted Jun 5, 2007·17 cites·13 claims
- 1287US7517531B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4US HEALTH·Filed 2004·Granted Apr 14, 2009·17 cites·42 claims
- 1385USRE46641EDengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Dec 19, 2017·5 cites·36 claims
- 1485US9783787B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4WHITEHEAD STEPHEN S·Filed 2011·Granted Oct 10, 2017·5 cites·9 claims
- 1585USRE45016EDevelopment of mutations useful for attenuating dengue viruses and chimeric dengue virusesUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2013·Granted Jul 15, 2014·4 cites·13 claims
- 1684US9707287B2Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural proteinTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Jul 18, 2017·3 cites·17 claims
- 1783US11746335B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2022·Granted Sep 5, 2023·0 cites·4 claims
- 1882US10058602B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2014·Granted Aug 28, 2018·3 cites·15 claims
- 1982USRE45053EAttenuated dengue virus comprising mutations in the NS3 geneUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH WASHINGTON D C·Filed 2013·Granted Jul 29, 2014·4 cites·16 claims
- 2080US11318196B2Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural proteinUS HEALTH·Filed 2019·Granted May 3, 2022·0 cites·16 claims
- 2176US11753627B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4US HEALTH·Filed 2020·Granted Sep 12, 2023·0 cites·4 claims
- 2276US11400150B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2020·Granted Aug 2, 2022·0 cites·9 claims
- 2374US11332722B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted May 17, 2022·0 cites·6 claims
- 2472US10837003B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4US HEALTH·Filed 2017·Granted Nov 17, 2020·0 cites·5 claims
- 2571US10724007B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Jul 28, 2020·0 cites·9 claims
- 2671US8778671B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusPLETNEV ALEXANDER G·Filed 2004·Granted Jul 15, 2014·4 cites·6 claims
- 2769US10869920B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2019·Granted Dec 22, 2020·0 cites·11 claims
- 2868US10500264B2Development of mutations useful for attenuating dengue viruses and chimeric dengue virusesUS HEALTH·Filed 2017·Granted Dec 10, 2019·0 cites·13 claims
- 2966US10849975B2Multivalent vaccines for rabies virus and filovirusesBLANEY JOSEPH E·Filed 2012·Granted Dec 1, 2020·1 cites·26 claims
- 3066US10456461B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2018·Granted Oct 29, 2019·0 cites·12 claims
- 3166US10160957B2Development of dengue virus vaccine componentsUS HEALTH·Filed 2015·Granted Dec 25, 2018·0 cites·6 claims
- 3266USRE45123ERecombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesisUS GOVERNMENT·Filed 2013·Granted Sep 9, 2014·0 cites·10 claims
- 3344US2010316670A1Chimeric sle/dengue type 4 antigenic virusesBLANEY JOSEPH E·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →